Hotaling Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-929
| Closed | -$350K | – | 133 |
|
|
2021
Q4 | $350K | Buy |
929
+9
| +1% | +$3.39K | 0.12% | 100 |
|
|
2021
Q3 | $380K | Buy |
920
+50
| +6% | +$20.7K | 0.16% | 90 |
|
|
2021
Q2 | $322K | Hold |
870
| – | – | 0.13% | 101 |
|
|
2021
Q1 | $252K | Sell |
870
-52
| -6% | -$15.1K | 0.11% | 98 |
|
|
2020
Q4 | $230K | Sell |
922
-14
| -1% | -$3.49K | 0.11% | 98 |
|
|
2020
Q3 | $212K | Buy |
+936
| New | +$212K | 0.11% | 102 |
|
|
2020
Q2 | – | Sell |
-1,670
| Closed | -$211K | – | 106 |
|
|
2020
Q1 | $211K | Sell |
1,670
-107
| -6% | -$13.5K | 0.16% | 93 |
|
|
2019
Q4 | $271K | Buy |
1,777
+15
| +0.9% | +$2.29K | 0.16% | 93 |
|
|
2019
Q3 | $233K | Buy |
1,762
+15
| +0.9% | +$1.98K | 0.15% | 96 |
|
|
2019
Q2 | $248K | Buy |
1,747
+20
| +1% | +$2.84K | 0.16% | 101 |
|
|
2019
Q1 | $251K | Buy |
+1,727
| New | +$251K | 0.17% | 103 |
|